HEADER OXIDOREDUCTASE 16-JAN-17 5MVD TITLE CRYSTAL STRUCTURE OF POTENT HUMAN DIHYDROOROTATE DEHYDROGENASE TITLE 2 INHIBITORS BASED ON HYDROXYLATED AZOLE SCAFFOLDS COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROOROTATE DEHYDROGENASE (QUINONE), MITOCHONDRIAL; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: DHODEHASE,DIHYDROOROTATE OXIDASE; COMPND 5 EC: 1.3.5.2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DHODH; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-19B KEYWDS DHODH, HUMAN DHODH, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR P.GOYAL,M.ANDERSSON,A.C.MORITZER,S.SAINAS,A.C.PIPPIONE,D.BOSCHI,S.AL- AUTHOR 2 KADARAGHI,M.LOLLI,R.FRIEMANN REVDAT 2 17-JAN-24 5MVD 1 REMARK REVDAT 1 08-MAR-17 5MVD 0 JRNL AUTH S.SAINAS,A.C.PIPPIONE,M.GIORGIS,E.LUPINO,P.GOYAL, JRNL AUTH 2 C.RAMONDETTI,B.BUCCINNA,M.PICCININI,R.C.BRAGA,C.H.ANDRADE, JRNL AUTH 3 M.ANDERSSON,A.C.MORITZER,R.FRIEMANN,S.MENSA,S.AL-KADARAGHI, JRNL AUTH 4 D.BOSCHI,M.L.LOLLI JRNL TITL DESIGN, SYNTHESIS, BIOLOGICAL EVALUATION AND X-RAY JRNL TITL 2 STRUCTURAL STUDIES OF POTENT HUMAN DIHYDROOROTATE JRNL TITL 3 DEHYDROGENASE INHIBITORS BASED ON HYDROXYLATED AZOLE JRNL TITL 4 SCAFFOLDS. JRNL REF EUR J MED CHEM V. 129 287 2017 JRNL REFN ISSN 1768-3254 JRNL PMID 28235702 JRNL DOI 10.1016/J.EJMECH.2017.02.017 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.43 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 43344 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.169 REMARK 3 R VALUE (WORKING SET) : 0.167 REMARK 3 FREE R VALUE : 0.202 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.840 REMARK 3 FREE R VALUE TEST SET COUNT : 2100 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 30.4293 - 4.8033 1.00 2928 142 0.1774 0.1721 REMARK 3 2 4.8033 - 3.8149 1.00 2789 165 0.1409 0.1583 REMARK 3 3 3.8149 - 3.3334 1.00 2747 154 0.1501 0.1928 REMARK 3 4 3.3334 - 3.0289 1.00 2773 130 0.1599 0.2010 REMARK 3 5 3.0289 - 2.8120 1.00 2739 147 0.1645 0.1966 REMARK 3 6 2.8120 - 2.6463 1.00 2781 113 0.1689 0.2086 REMARK 3 7 2.6463 - 2.5138 1.00 2742 120 0.1602 0.2279 REMARK 3 8 2.5138 - 2.4044 1.00 2752 130 0.1633 0.1898 REMARK 3 9 2.4044 - 2.3119 1.00 2731 139 0.1703 0.2291 REMARK 3 10 2.3119 - 2.2321 1.00 2714 155 0.1676 0.2430 REMARK 3 11 2.2321 - 2.1624 1.00 2698 137 0.1696 0.1988 REMARK 3 12 2.1624 - 2.1006 1.00 2713 153 0.1797 0.2234 REMARK 3 13 2.1006 - 2.0453 1.00 2677 159 0.1946 0.2247 REMARK 3 14 2.0453 - 1.9954 1.00 2725 141 0.2086 0.2592 REMARK 3 15 1.9954 - 1.9500 1.00 2735 115 0.2277 0.2923 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.180 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 17.150 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.83 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.016 2811 REMARK 3 ANGLE : 1.400 3814 REMARK 3 CHIRALITY : 0.080 425 REMARK 3 PLANARITY : 0.009 500 REMARK 3 DIHEDRAL : 12.078 1687 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5MVD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-JAN-17. REMARK 100 THE DEPOSITION ID IS D_1200003070. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-SEP-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.872 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM, MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.21 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43390 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 78.679 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 9.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.20000 REMARK 200 FOR THE DATA SET : 9.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.06 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 9.20 REMARK 200 R MERGE FOR SHELL (I) : 0.75200 REMARK 200 R SYM FOR SHELL (I) : 0.75200 REMARK 200 FOR SHELL : 1.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4YLW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 68.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.87 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M KBR, 0.2M KSCN, 0.1M NAAC PH 5.2, REMARK 280 35% PEG 400, 5% PGA-LM, PH 5.0, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.94933 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 40.97467 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 40.97467 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 81.94933 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14320 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 70 REMARK 465 ALA A 71 REMARK 465 ARG A 72 REMARK 465 PHE A 73 REMARK 465 GLN A 74 REMARK 465 ASN A 217 REMARK 465 THR A 218 REMARK 465 ALA A 219 REMARK 465 GLY A 220 REMARK 465 LEU A 221 REMARK 465 ARG A 222 REMARK 465 SER A 223 REMARK 465 LEU A 224 REMARK 465 GLN A 225 REMARK 465 GLY A 226 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 99 74.32 -109.39 REMARK 500 VAL A 213 38.01 -98.10 REMARK 500 TYR A 356 -62.28 -140.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FMN A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ORO A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue U91 A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 407 DBREF 5MVD A 34 396 UNP Q02127 PYRD_HUMAN 33 395 SEQRES 1 A 363 ASP GLU ARG PHE TYR ALA GLU HIS LEU MET PRO THR LEU SEQRES 2 A 363 GLN GLY LEU LEU ASP PRO GLU SER ALA HIS ARG LEU ALA SEQRES 3 A 363 VAL ARG PHE THR SER LEU GLY LEU LEU PRO ARG ALA ARG SEQRES 4 A 363 PHE GLN ASP SER ASP MET LEU GLU VAL ARG VAL LEU GLY SEQRES 5 A 363 HIS LYS PHE ARG ASN PRO VAL GLY ILE ALA ALA GLY PHE SEQRES 6 A 363 ASP LYS HIS GLY GLU ALA VAL ASP GLY LEU TYR LYS MET SEQRES 7 A 363 GLY PHE GLY PHE VAL GLU ILE GLY SER VAL THR PRO LYS SEQRES 8 A 363 PRO GLN GLU GLY ASN PRO ARG PRO ARG VAL PHE ARG LEU SEQRES 9 A 363 PRO GLU ASP GLN ALA VAL ILE ASN ARG TYR GLY PHE ASN SEQRES 10 A 363 SER HIS GLY LEU SER VAL VAL GLU HIS ARG LEU ARG ALA SEQRES 11 A 363 ARG GLN GLN LYS GLN ALA LYS LEU THR GLU ASP GLY LEU SEQRES 12 A 363 PRO LEU GLY VAL ASN LEU GLY LYS ASN LYS THR SER VAL SEQRES 13 A 363 ASP ALA ALA GLU ASP TYR ALA GLU GLY VAL ARG VAL LEU SEQRES 14 A 363 GLY PRO LEU ALA ASP TYR LEU VAL VAL ASN VAL SER SER SEQRES 15 A 363 PRO ASN THR ALA GLY LEU ARG SER LEU GLN GLY LYS ALA SEQRES 16 A 363 GLU LEU ARG ARG LEU LEU THR LYS VAL LEU GLN GLU ARG SEQRES 17 A 363 ASP GLY LEU ARG ARG VAL HIS ARG PRO ALA VAL LEU VAL SEQRES 18 A 363 LYS ILE ALA PRO ASP LEU THR SER GLN ASP LYS GLU ASP SEQRES 19 A 363 ILE ALA SER VAL VAL LYS GLU LEU GLY ILE ASP GLY LEU SEQRES 20 A 363 ILE VAL THR ASN THR THR VAL SER ARG PRO ALA GLY LEU SEQRES 21 A 363 GLN GLY ALA LEU ARG SER GLU THR GLY GLY LEU SER GLY SEQRES 22 A 363 LYS PRO LEU ARG ASP LEU SER THR GLN THR ILE ARG GLU SEQRES 23 A 363 MET TYR ALA LEU THR GLN GLY ARG VAL PRO ILE ILE GLY SEQRES 24 A 363 VAL GLY GLY VAL SER SER GLY GLN ASP ALA LEU GLU LYS SEQRES 25 A 363 ILE ARG ALA GLY ALA SER LEU VAL GLN LEU TYR THR ALA SEQRES 26 A 363 LEU THR PHE TRP GLY PRO PRO VAL VAL GLY LYS VAL LYS SEQRES 27 A 363 ARG GLU LEU GLU ALA LEU LEU LYS GLU GLN GLY PHE GLY SEQRES 28 A 363 GLY VAL THR ASP ALA ILE GLY ALA ASP HIS ARG ARG HET FMN A 401 31 HET ORO A 402 11 HET U91 A 403 27 HET ACT A 404 4 HET ACT A 405 4 HET CL A 406 1 HET CL A 407 1 HET CL A 408 1 HETNAM FMN FLAVIN MONONUCLEOTIDE HETNAM ORO OROTIC ACID HETNAM U91 1,5-DIMETHYL-3-OXIDANYL-~{N}-[2,3,5,6- HETNAM 2 U91 TETRAKIS(FLUORANYL)-4-PHENYL-PHENYL]PYRAZOLE-4- HETNAM 3 U91 CARBOXAMIDE HETNAM ACT ACETATE ION HETNAM CL CHLORIDE ION HETSYN FMN RIBOFLAVIN MONOPHOSPHATE FORMUL 2 FMN C17 H21 N4 O9 P FORMUL 3 ORO C5 H4 N2 O4 FORMUL 4 U91 C18 H13 F4 N3 O2 FORMUL 5 ACT 2(C2 H3 O2 1-) FORMUL 7 CL 3(CL 1-) FORMUL 10 HOH *233(H2 O) HELIX 1 AA1 ASP A 34 HIS A 41 1 8 HELIX 2 AA2 HIS A 41 LEU A 50 1 10 HELIX 3 AA3 ASP A 51 LEU A 65 1 15 HELIX 4 AA4 SER A 76 GLU A 80 5 5 HELIX 5 AA5 ALA A 104 GLY A 112 1 9 HELIX 6 AA6 PRO A 138 ASP A 140 5 3 HELIX 7 AA7 GLY A 153 ALA A 163 1 11 HELIX 8 AA8 ARG A 164 ASP A 174 1 11 HELIX 9 AA9 ASP A 190 GLY A 203 1 14 HELIX 10 AB1 PRO A 204 ALA A 206 5 3 HELIX 11 AB2 ALA A 228 GLY A 243 1 16 HELIX 12 AB3 ARG A 245 ARG A 249 5 5 HELIX 13 AB4 THR A 261 GLY A 276 1 16 HELIX 14 AB5 LEU A 309 THR A 324 1 16 HELIX 15 AB6 SER A 338 GLY A 349 1 12 HELIX 16 AB7 TYR A 356 GLY A 363 1 8 HELIX 17 AB8 PRO A 365 GLN A 381 1 17 HELIX 18 AB9 GLY A 385 ILE A 390 1 6 HELIX 19 AC1 GLY A 391 ARG A 396 5 6 SHEET 1 AA1 2 VAL A 81 VAL A 83 0 SHEET 2 AA1 2 HIS A 86 PHE A 88 -1 O PHE A 88 N VAL A 81 SHEET 1 AA2 9 VAL A 92 ILE A 94 0 SHEET 2 AA2 9 PHE A 115 VAL A 121 1 O PHE A 115 N ILE A 94 SHEET 3 AA2 9 LEU A 178 LEU A 182 1 O GLY A 179 N VAL A 116 SHEET 4 AA2 9 TYR A 208 ASN A 212 1 O VAL A 210 N LEU A 182 SHEET 5 AA2 9 ALA A 251 ILE A 256 1 O ALA A 251 N LEU A 209 SHEET 6 AA2 9 GLY A 279 VAL A 282 1 O ILE A 281 N VAL A 254 SHEET 7 AA2 9 ILE A 330 VAL A 333 1 O ILE A 331 N LEU A 280 SHEET 8 AA2 9 LEU A 352 LEU A 355 1 O LEU A 352 N GLY A 332 SHEET 9 AA2 9 VAL A 92 ILE A 94 1 N GLY A 93 O VAL A 353 SHEET 1 AA3 3 VAL A 134 LEU A 137 0 SHEET 2 AA3 3 ALA A 142 ASN A 145 -1 O ALA A 142 N LEU A 137 SHEET 3 AA3 3 GLY A 303 GLY A 306 -1 O GLY A 303 N ASN A 145 CISPEP 1 GLY A 119 SER A 120 0 5.34 CISPEP 2 ARG A 131 PRO A 132 0 -1.09 CISPEP 3 VAL A 282 THR A 283 0 11.89 SITE 1 AC1 25 ALA A 95 ALA A 96 GLY A 97 LYS A 100 SITE 2 AC1 25 GLY A 119 SER A 120 ASN A 145 ASN A 181 SITE 3 AC1 25 ASN A 212 LYS A 255 THR A 283 ASN A 284 SITE 4 AC1 25 THR A 285 SER A 305 GLY A 306 LEU A 309 SITE 5 AC1 25 VAL A 333 GLY A 334 GLY A 335 LEU A 355 SITE 6 AC1 25 TYR A 356 THR A 357 ORO A 402 HOH A 517 SITE 7 AC1 25 HOH A 574 SITE 1 AC2 11 LYS A 100 ASN A 145 TYR A 147 GLY A 148 SITE 2 AC2 11 PHE A 149 ASN A 212 SER A 215 PRO A 216 SITE 3 AC2 11 ASN A 284 THR A 285 FMN A 401 SITE 1 AC3 12 MET A 43 LEU A 46 ALA A 55 HIS A 56 SITE 2 AC3 12 ALA A 59 LEU A 67 LEU A 68 VAL A 134 SITE 3 AC3 12 ARG A 136 TYR A 356 THR A 360 HOH A 536 SITE 1 AC4 5 ALA A 169 THR A 172 LEU A 205 ASP A 207 SITE 2 AC4 5 HOH A 522 SITE 1 AC5 7 LYS A 307 PRO A 308 ASP A 311 THR A 314 SITE 2 AC5 7 GLN A 315 ARG A 318 HOH A 586 SITE 1 AC6 5 GLN A 165 PRO A 204 HIS A 248 ARG A 298 SITE 2 AC6 5 SER A 299 SITE 1 AC7 3 PRO A 52 ARG A 136 HOH A 646 CRYST1 90.850 90.850 122.924 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011007 0.006355 0.000000 0.00000 SCALE2 0.000000 0.012710 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008135 0.00000